Monday, November 17, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Consumer & Luxury

Lululemon’s Stock Plunge: Can International Growth Offset Domestic Weakness?

Felix Baarz by Felix Baarz
November 17, 2025
in Consumer & Luxury, Earnings, Turnaround
0
Lululemon Stock
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

The athletic apparel retailer Lululemon, once a celebrated growth stock, is confronting a significant challenge. Its core North American business is faltering, dragging share prices downward, even as its international operations show robust expansion. The critical question for investors is whether the company can orchestrate a recovery or if the decline will persist.

Analyst Sentiment: A Cautious Stance

Market experts are largely maintaining a “hold” rating on Lululemon’s shares, reflecting a market caught between doubt and optimism. While clear buy or sell signals are absent, price targets have been adjusted downwards. These revised forecasts, now ranging from $195 to $230, still sit notably above the current trading level, highlighting a conflicted outlook.

The company’s present valuation is a key point of discussion. Shares are currently trading at approximately 12 to 13 times expected earnings, a multiple that appears historically attractive. Some observers consider the stock undervalued, pointing to Lululemon’s powerful brand identity and a balance sheet free of debt. However, the central uncertainty remains: are these strengths sufficient to counterbalance the severe downturn in its home market?

North American Core Business Faces Headwinds

The company’s most pressing issue became clear in its second-quarter 2025 report. Although Lululemon posted overall revenue growth of 7%, reaching $2.5 billion, its performance in the United States and Canada was dismal. Comparable sales in this crucial region dropped by 4%, an alarming indicator of trouble at home. This weakness is attributed to subdued consumer spending and a product lineup that has lost its innovative edge.

Should investors sell immediately? Or is it worth buying Lululemon?

In response to these challenges, management was forced to issue a starkly reduced annual forecast. Instead of previously anticipated strong gains, the company now projects revenue growth of just 2-4% for the full year 2025. The profit outlook is even more concerning, with expected earnings per share forecast to plummet by roughly 12%. This guidance triggered a sharp negative reaction from investors, leading to a substantial sell-off.

International Expansion Provides a Glimmer of Hope

Contrasting the domestic slump, Lululemon’s international segment continues to be a powerhouse. In the second quarter, revenue outside its home markets surged by 22%. The Chinese market was a particular standout, boasting impressive growth of 25% and establishing itself as a primary engine for new growth.

This international strength may serve as the company’s crucial lifeline. While the American market shows signs of saturation, emerging economies and Europe present substantial untapped potential. Currently, the successful expansion beyond North America seems to be the primary reason investors are retaining any confidence in the company’s long-term strategy.

All eyes are now on the upcoming quarterly report in December. This release is expected to reveal whether Lululemon’s leadership has a viable plan to revitalize its American business, or if the impressive international performance will be inadequate to halt the overall downward trend.

Ad

Lululemon Stock: Buy or Sell?! New Lululemon Analysis from November 17 delivers the answer:

The latest Lululemon figures speak for themselves: Urgent action needed for Lululemon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 17.

Lululemon: Buy or sell? Read more here...

Tags: Lululemon
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Axsome Stock
Earnings

Axsome Therapeutics: Neuroscience Innovator Gains Momentum

November 17, 2025
BAE Systems Stock
Defense & Aerospace

BAE Systems Shares Surge on Strong Defense Orders

November 17, 2025
Bruker Stock
Analysis

Bruker Shares: Navigating the Crossroads After a Sharp Downturn

November 17, 2025
Next Post
Warner Bros. Discovery (A) Stock

Acquisition Battle Intensifies for Warner Bros. Discovery

Boeing Stock

Boeing's Survival Battle: Multiple Crises Converge on Aviation Titan

Coeur Mining Stock

Coeur Mining's Ambitious Acquisition: Strategic Masterstroke or Overextension?

Recommended

Technology Blockchain Trading online

Calculating Shares Needed for Monthly Income from Cisco Systems Dividends

2 years ago
Abercrombie & Fitch Stock

Abercrombie & Fitch Shares Approach Critical Juncture

6 days ago

ESAB Corporation Analysts Bullish on Stock Growth

2 years ago
Navitas Semiconductor Corporation Stock

Navitas Semiconductor: A Battle Between Short-Term Pressures and Long-Term Strategy

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Bruker Shares: Navigating the Crossroads After a Sharp Downturn

Meta’s AI Ambitions Fuel Investor Divide

Hannover Re Shares Surge on Upbeat Financial Outlook

Synopsys Faces Securities Lawsuit Amid Major Corporate Overhaul

Sunnova Energy’s Final Chapter: Liquidation Complete as Solar Pioneer Ceases Operations

Disney’s Strategic Pivot: Navigating Challenges with Renewed Focus

Trending

Axsome Stock
Earnings

Axsome Therapeutics: Neuroscience Innovator Gains Momentum

by Andreas Sommer
November 17, 2025
0

The biotechnology sector has identified its latest standout performer: Axsome Therapeutics. This pharmaceutical firm is rapidly establishing...

BAE Systems Stock

BAE Systems Shares Surge on Strong Defense Orders

November 17, 2025
Zoetis Stock

Zoetis Shares: Is the Downturn Bottoming Out?

November 17, 2025
Bruker Stock

Bruker Shares: Navigating the Crossroads After a Sharp Downturn

November 17, 2025
Meta Stock

Meta’s AI Ambitions Fuel Investor Divide

November 17, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Axsome Therapeutics: Neuroscience Innovator Gains Momentum
  • BAE Systems Shares Surge on Strong Defense Orders
  • Zoetis Shares: Is the Downturn Bottoming Out?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com